CEAT Limited — Important, 18-03-2025: Updates

The Board of Directors has made several important decisions that could influence the company's trajectory. Dr. Santrupt Misra has been appointed as an Additional Director, specifically as a Non-Executive, Independent Director, for a five-year term, pending shareholder approval via Postal Ballot. The Nomination and Remuneration Committee (NRC) has also been restructured to include Dr. Misra as a member.

In a strategic move to motivate employees, the company is initiating the CEAT Employees Stock Option Scheme 2025, aimed at granting options to eligible employees. This scheme will follow the Trust route, allowing for secondary acquisitions from the market, with a proposed pool of 400,000 shares. Shareholder approval will be sought through Postal Ballot.

Lastly, amendments to the Nomination and Remuneration Policy and the Policy for determining Material Subsidiaries were approved. The initial capital of the Indonesia subsidiary has been revised to IDR 10 billion (approximately INR 5.31 Cr). These developments reflect a focus on governance and employee engagement, indicating a positive outlook as the company positions itself for future growth.